19 Jan 2016 --- Biological solutions firm Novozymes has announced that in 2015 grew by 4% organically and by 12% in financial terms. EBIT grew by 15%, and the EBIT margin was 27.7%. Net profit grew by 12%. In Q4, sales grew by 2% organically and by 9% in Danish Kroner compared with Q4 2014.
